Poster Submission
Poster submission for the Special Focus Meeting are now open.
Deadline for applications: Thursday 17th December 2026, 23.59 CET.
Members must be logged in to apply.
Terms & Conditions
The programme for the Special Focus Meeting taking place in Ljubljana on 26th and 27th February 2027 will focus on Inherited Retinal Diseases.
Accepted abstracts will be exhibited as physical paper posters on poster boards.
Prizes of complimentary registration for the Copenhagen 2027 Congress will be awarded to the best posters.
– The Poster abstract submission portal will close on Thursday 17th December 2026.
– Please note that you must be a Euretina Member in order to submit a Poster abstract. If you are not a member please CLICK HERE to join. (Under the Euretina YOURS initiative, ophthalmologists under 40 can avail of free Euretina membership for 3 years.)
– Each applicant may submit a maximum of 2 Poster abstracts.
– If you choose to submit an abstract(s) we will use your personal details to keep you updated on its status including whether it has been accepted for presentation at the Special Focus Meeting.
– If your poster is accepted for presentation full details of Poster requirements will be sent to you in due course.
– If you wish to withdraw your accepted abstract from the programme, you must confirm via email to [email protected] by Tuesday 16th February, 2027
Please Note: Due to the high level of interest in submissions, we are unable to provide individual feedback to applicants following the review process.
Submission Format
Poster Abstracts should be submitted under the topic of Inherited Retinal Diseases. You can submit under the following themes; Genotype-phenotype Correlations, Clinical Trials, Differential Diagnoses, Clinical Investigations, Epidemiology, Other.
All submitted abstracts must be in English and follow the structured format below:
– Title (250 characters max)
– Purpose (100 words max): Should include a brief summary and concise goal of the study.
– Setting/Venue (50 words max)
– Methods (200 words max): Should include descriptions of the inclusion/exclusion criteria, experiments performed, outcome measures, data analysis procedures and statistical analysis procedure.
– Results (200 words max): Should be qualitative data and/or quantitative data with proper statistical information. Figures or tables can be included.
– Conclusions (200 words max): Should be a concise conclusion based on the evidence presented in the Results section and addressing the question/hypothesis stated in the Purpose section.
Financial Disclosure: Please indicate Yes/No.
If applicable, please clearly list your financial interest in the subject matter, including whether you receive funds from any mentioned companies.
Review & Evaluation
– All submitted abstracts will be reviewed by a panel of experts before a final selection is made.
– The decision of the Euretina Review Committee is final.
– If your poster abstract is accepted for presentation, you will be informed of this by email by the end of January 2027.
Further Instructions
– Presentation titles must not include company names.
– Accepted Posters must not include company logos.
– The summary of results presented must be given in sufficient detail to support the conclusions. The Review Committee will only accept abstracts with final results or conclusions.
– Formulae should, in general, be avoided.
– When using abbreviations or acronyms for the first time, care should be taken to spell them out in full with the abbreviation in parentheses after the full word(s) the first time it appears in the text. The abbreviation should be used alone thereafter.
– Euretina does not take any ownership of the copyright of a presentation. However, presenters are required to sign a Transfer of Rights document at the time of the presentation upload.
For any queries, please contact [email protected].